Transplant indications, guidelines and recommendations: Caveat Emptor

• by Robert Peter Gale, Giovanni Barosi

• October 28, 2021

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced practitioners to effectively manage the most common toxicities associated with nivolumab-AVD.

• by Maria D. Guerrero

• May 6, 2026

• 13 min

Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies

• by Tingting Li, Chaoyu Wang, Qing Xiao, Xiaomei Zhang, Zailin Yang, Jun Li, Yao Liu

• February 25, 2026

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

Preet M. Chaudhary, MD, PhD, discusses the repeat ranking of the USC Norris Blood and Marrow Transplant and Cell Therapy Program as one of the nation’s elite allogeneic transplant programs with the highest survival outcomes.

• by

• February 13, 2026

• 12 min